Company news
Samsung Biologics Co., Ltd. (KRX:207940) news
Samsung Biologics Co., Ltd. news releases on 6ix. Latest, Aug 31, 2026: Samsung Biologics publishes prospectus for PolyPeptide public tender offer
Press releases & updates
Samsung Biologics publishes prospectus for PolyPeptide public tender offer
August 31, 2026
Samsung Biologics Reports Second Quarter 2026 Financial Results
July 22, 2026
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
July 19, 2026
Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth
June 30, 2026
Samsung Biologics : 2025 FY Audited Financial Statements (Consolidated)
May 20, 2026
Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline
May 6, 2026
Samsung Biologics Listed on Dow Jones Best-in-Class World Index for Fifth Consecutive Year
May 5, 2026
Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech Innovation in Asia-Pacific
April 29, 2026
Samsung Biologics Reports First Quarter 2026 Financial Results
April 22, 2026
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland
March 31, 2026
Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
March 26, 2026
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
March 12, 2026
Samsung Biologics Announces Collaboration with Lilly to Establish New Gateway Labs Site in Korea
March 10, 2026
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system
February 6, 2026
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
February 3, 2026
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
January 28, 2026
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 19, 2026
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
December 21, 2025
Samsung Biologics recognized as a global leader in water security
December 10, 2025
Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO
November 3, 2025
Newly Established Samsung Epis Holdings to Drive Growth for Samsung Bioepis and a New Subsidiary
November 2, 2025
Samsung Biologics reports third quarter 2025 financial results
October 28, 2025
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™
October 9, 2025
Samsung Biologics reports second quarter 2025 financial results
July 23, 2025
Samsung Biologics launches drug screening services, Samsung Organoids
June 15, 2025
Samsung Biologics reports first quarter 2025 financial results
April 23, 2025
Samsung Biologics recognized for leadership band in water security
February 12, 2025
Samsung Biologics reports fourth quarter and fiscal year 2024 financial results
January 22, 2025
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
January 14, 2025